Testogel 16.2
$55.00
Iron Ascension Testogel 16.2 (Testosterone Gel 1.62%) is a advanced transdermal androgen delivery system engineered for steady, continuous systemic hormone absorption. Formulated with a specialized hydroalcoholic carrier, it penetrates the stratum corneum rapidly to elevate serum testosterone levels without the concentration spikes and troughs associated with short-acting injectable esters.
Guaranteed safe checkout
Description
Description
Iron Ascension Testogel 16.2
Specifications & Composition
| Specification | Details |
|---|---|
| Active Compound | Testosterone (unesterified) |
| Concentration | 16.2 mg/g (1.62%) |
| Total Quantity | 88 g metered-actuation pump |
| Delivery System | Topically applied hydroalcoholic gel |
| Formulation Standard | Pharmaceutical grade (manufacturer claim; verification required) |
| Batch Testing | High-Performance Liquid Chromatography (HPLC) |
Key Performance Features
- Testosterone Replacement: Transdermal testosterone delivers testosterone through the skin into systemic circulation. When medically indicated for confirmed testosterone deficiency, it can help restore levels toward an individual’s prescribed physiological range.
- Transdermal Delivery: The hydroalcoholic gel vehicle facilitates skin absorption and typically dries after application. Absorption varies between individuals, and drying does not eliminate the risk of transfer to other people through skin contact.
- Needle-Free Administration: Provides a non-injectable testosterone replacement option. Its suitability depends on clinical assessment, laboratory results, and ongoing monitoring.
Important Health Considerations: Testosterone therapy can suppress natural testosterone production and sperm production, potentially impairing fertility. Other risks include elevated hematocrit, acne, fluid retention, and changes in prostate-related markers. Accidental transfer to women and children can cause unwanted androgen exposure. Application sites should be managed according to the approved product instructions, including washing hands and covering the treated area once dry.
Quality Control & Lab Verification
The manufacturer reports that each batch undergoes quantitative testing before allocation.
| Quality Control Parameter | Reported Result |
|---|---|
| Compound | Testosterone Gel 1.62% (transdermal) |
| Assay Result | 99.7% active compound (reported) |
| Testing Method | HPLC (reported) |
| Verification Status | PASSED (reported) |
Publication note: The 99.7% assay result, HPLC report, pharmaceutical-grade designation, gel concentration, pump metering accuracy, and formulation should be verified against a genuine, batch-specific certificate of analysis. HPLC assay alone does not establish dose-delivery consistency, skin absorption, microbial quality, or product safety.
Specifications
- Short Stroke Gas Piston Gas System (Rifle Length)
- 18.6″ Barrel Length ( Mid-Weight style, non-fluted)
- 1:8 Twist Rate Rifling
Reviews
There are no reviews yet.